Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Ceschi

Showing results (11-20 of 113) with videos related to

Pageof 12
Sort By:
Swiss Medical Weekly|September 11, 2013
Swiss prospective study on spider bitesMarkus Gnädinger, Wolfgang Nentwig, Joan Fuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2022
Reply to Gremese et al.: Statistical reasoning to evaluate treatment effects when data are collected with lack of design: Covid-19 experienceClelia Di Serio, Pietro Cippà, Alessandro Ceschi, et al.
Current Therapeutic Research, Clinical and Experimental|July 26, 2021
The Contribution of Clinical Pharmacologists in Precision Medicine: An Opportunity for Health Care ImprovementDavide Grisafi, Alessandro Ceschi, Veronica Avalos Clerici, et al.
Scientific Reports|August 14, 2020
Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European dataGiulia Bonaldo, Roberta Noseda, Alessandro Ceschi, et al.
Cephalalgia : an International Journal of Headache|March 1, 2023
Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®Roberta Noseda, Francesca Bedussi, Claudio Gobbi, et al.
The Journal of Headache and Pain|January 19, 2024
Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase<sup>®</sup>Roberta Noseda, Francesca Bedussi, Claudio Gobbi, et al.
European Journal of Clinical Pharmacology|November 25, 2010
Paracetamol orodispersible tablets: a risk for severe poisoning in children?Alessandro Ceschi, Katharina E Hofer, Christine Rauber-Lüthy, et al.
European Journal of Clinical Pharmacology|October 18, 2022
Spikevax booster and delayed urticaria: a Swiss signal with diagnostic uncertainties due to a high proportion of direct patient reportsRoberta Noseda, Laura Müller, Thomas Stammschulte, et al.
Cancers|April 3, 2021
Adverse Event Reporting with Immune Checkpoint Inhibitors in Older Patients: Age Subgroup Disproportionality Analysis in VigiBaseRoberta Noseda, Giulia Bonaldo, Domenico Motola, et al.
Cephalalgia : an International Journal of Headache|May 3, 2021
Reply to the Letter to the Editor by Kessler Y et al. regarding the manuscript "Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database."Roberta Noseda, Francesca Bedussi, Claudio Gobbi, et al.
Pageof 12

Showing results (11-20 of 113) with videos related to

Sort By:
Pageof 12
Swiss Medical Weekly|September 11, 2013
Swiss prospective study on spider bitesMarkus Gnädinger, Wolfgang Nentwig, Joan Fuchs, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2022
Reply to Gremese et al.: Statistical reasoning to evaluate treatment effects when data are collected with lack of design: Covid-19 experienceClelia Di Serio, Pietro Cippà, Alessandro Ceschi, et al.
Current Therapeutic Research, Clinical and Experimental|July 26, 2021
The Contribution of Clinical Pharmacologists in Precision Medicine: An Opportunity for Health Care ImprovementDavide Grisafi, Alessandro Ceschi, Veronica Avalos Clerici, et al.
Scientific Reports|August 14, 2020
Evaluation of the safety profile of rotavirus vaccines: a pharmacovigilance analysis on American and European dataGiulia Bonaldo, Roberta Noseda, Alessandro Ceschi, et al.
Cephalalgia : an International Journal of Headache|March 1, 2023
Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®Roberta Noseda, Francesca Bedussi, Claudio Gobbi, et al.
The Journal of Headache and Pain|January 19, 2024
Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase<sup>®</sup>Roberta Noseda, Francesca Bedussi, Claudio Gobbi, et al.
European Journal of Clinical Pharmacology|November 25, 2010
Paracetamol orodispersible tablets: a risk for severe poisoning in children?Alessandro Ceschi, Katharina E Hofer, Christine Rauber-Lüthy, et al.
European Journal of Clinical Pharmacology|October 18, 2022
Spikevax booster and delayed urticaria: a Swiss signal with diagnostic uncertainties due to a high proportion of direct patient reportsRoberta Noseda, Laura Müller, Thomas Stammschulte, et al.
Cancers|April 3, 2021
Adverse Event Reporting with Immune Checkpoint Inhibitors in Older Patients: Age Subgroup Disproportionality Analysis in VigiBaseRoberta Noseda, Giulia Bonaldo, Domenico Motola, et al.
Cephalalgia : an International Journal of Headache|May 3, 2021
Reply to the Letter to the Editor by Kessler Y et al. regarding the manuscript "Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database."Roberta Noseda, Francesca Bedussi, Claudio Gobbi, et al.
Pageof 12